Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel
Authors
Keywords
Drug resistant, Gastric cancer, MAPT, Methylation, miR-34c-5p, Paclitaxel
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 5, Pages 1159-1171
Publisher
Springer Nature
Online
2013-02-20
DOI
10.1007/s00280-013-2108-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastric Cancer
- (2017) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- MiR-34 and SNAIL: Another double-negative feedback loop controlling cellular plasticity/EMT governed by p53
- (2012) Thomas Brabletz CELL CYCLE
- miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
- (2012) S Catuogno et al. ONCOGENE
- MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
- (2012) S Yang et al. ONCOGENE
- Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
- (2011) Jing Gao et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of Tau protein in resistance to paclitaxel
- (2011) Marta Smoter et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma
- (2011) T. Kubo et al. CLINICAL CANCER RESEARCH
- Practical Aspects of microRNA Target Prediction
- (2011) T. M. Witkos et al. CURRENT MOLECULAR MEDICINE
- Epigenetic regulation of miRNA genes in acute leukemia
- (2011) X Agirre et al. LEUKEMIA
- miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
- (2011) A Holleman et al. ONCOGENE
- p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
- (2011) N. H. Kim et al. Science Signaling
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?
- (2010) Ian Cannell et al. CELL CYCLE
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions
- (2010) Zandra Hagman et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available
- (2010) Vladimir Benes et al. METHODS
- Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples
- (2009) Chunlei He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- Role of microRNA in anticancer drug resistance
- (2009) Tongsen Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel
- (2008) Q.-Q. Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Microtubule Active Agents: Beyond the Taxane Frontier
- (2008) P. G. Morris et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now